News


January 20, 2021

Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Marburg – Germany and enters into a 5-year strategic agreement with GSK

January 15, 2021

Announcing vivitide, a New Name With Continuous Commitment to Science Based on Long Experience in the World of Peptides and Antibodies

January 5, 2021

Genezen Laboratories Receives Growth Equity Investment from Ampersand Capital Partners

December 7, 2020

Adaptas Solutions Acquires Cadence Fluidics

December 2, 2020

N2 Biomedical Appoints Eric Tobin To Chief Executive Officer

December 1, 2020

Ampersand Capital Partners Establishes Portfolio Acceleration Team

November 19, 2020

Ampersand Announced Today the $670 Million Closing of the Ampersand Continuation Fund (“AMP-CF”) with Confluent Medical Technologies as Core Asset

November 11, 2020

With new CEO on board, Germany’s Vibalogics lays out $150M for Boston viral vector site

October 21, 2020

StageBio Expands Its Global Presence With Acquisition of TPL Path Labs

October 2, 2020

CEPI establishes global network of laboratories to centralise assessment of COVID-19 vaccine candidates